1. Home
  2. LEGN vs NNN Comparison

LEGN vs NNN Comparison

Compare LEGN & NNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • NNN
  • Stock Information
  • Founded
  • LEGN 2014
  • NNN 1984
  • Country
  • LEGN United States
  • NNN United States
  • Employees
  • LEGN N/A
  • NNN N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • NNN Real Estate Investment Trusts
  • Sector
  • LEGN Health Care
  • NNN Real Estate
  • Exchange
  • LEGN Nasdaq
  • NNN Nasdaq
  • Market Cap
  • LEGN 7.0B
  • NNN 7.9B
  • IPO Year
  • LEGN 2020
  • NNN N/A
  • Fundamental
  • Price
  • LEGN $31.08
  • NNN $40.82
  • Analyst Decision
  • LEGN Strong Buy
  • NNN Hold
  • Analyst Count
  • LEGN 13
  • NNN 11
  • Target Price
  • LEGN $79.42
  • NNN $44.70
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • NNN 1.2M
  • Earning Date
  • LEGN 05-13-2025
  • NNN 05-01-2025
  • Dividend Yield
  • LEGN N/A
  • NNN 5.68%
  • EPS Growth
  • LEGN N/A
  • NNN N/A
  • EPS
  • LEGN N/A
  • NNN 2.14
  • Revenue
  • LEGN $728,303,000.00
  • NNN $884,713,000.00
  • Revenue This Year
  • LEGN $65.96
  • NNN $4.10
  • Revenue Next Year
  • LEGN $52.55
  • NNN $4.32
  • P/E Ratio
  • LEGN N/A
  • NNN $19.09
  • Revenue Growth
  • LEGN 112.46
  • NNN 5.40
  • 52 Week Low
  • LEGN $29.27
  • NNN $35.80
  • 52 Week High
  • LEGN $60.87
  • NNN $49.57
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 39.41
  • NNN 45.17
  • Support Level
  • LEGN $30.25
  • NNN $40.21
  • Resistance Level
  • LEGN $33.30
  • NNN $42.50
  • Average True Range (ATR)
  • LEGN 1.53
  • NNN 0.71
  • MACD
  • LEGN -0.18
  • NNN -0.01
  • Stochastic Oscillator
  • LEGN 26.21
  • NNN 26.64

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About NNN NNN REIT Inc.

NNN REIT Inc is a real estate investment trust that invests in and develops properties throughout the United States. The company generates revenue from leasing properties to tenants, including convenience stores, automotive services, fitness centers, theatres, restaurants, and banks. Rents from convenience stores and restaurants contribute the majority proportion of total revenue. The maximum of the company's properties are located in the South and Southeast of the United States.

Share on Social Networks: